Panel Discussion – Barriers to Development of CD73/CD39 Mono and Combo Therapies and Potential Solutions
Time: 11:30 am
day: Day Two
Details:
- Compare and contrast single vs dual inhibition of adenosine enzymes
- Explore current challenges with identifying and validating predictive biomarkers of response
- Suggest methods and technologies worth pursuing to better select patients for trials
